| Literature DB >> 33240478 |
Elizabeth Manias1, Snezana Kusljic2, Angela Wu3.
Abstract
BACKGROUND AND AIMS: Medication errors occur at any point of the medication management process, and are a major cause of death and harm globally. The objective of this review was to compare the effectiveness of different interventions in reducing prescribing, dispensing and administration medication errors in acute medical and surgical settings.Entities:
Keywords: hospitals; medical order entry systems; medication errors; medication reconciliation; medication therapy management; nurses; patient safety; pharmacists; physicians; systematic review
Year: 2020 PMID: 33240478 PMCID: PMC7672746 DOI: 10.1177/2042098620968309
Source DB: PubMed Journal: Ther Adv Drug Saf ISSN: 2042-0986
Overview of studies included in the systematic review (n = 34).
| Reference (country) | Study design | Setting | Number of patients | Intervention type | Type of medication error analysed (method of data collection for medication errors), effect of intervention on medication error rate |
|---|---|---|---|---|---|
|
| |||||
| Al-Hashar | Prospective randomised controlled study | Medical wards of a tertiary care academic hospital with a bed capacity of 500 | 286 (intervention), 301 (control) | Pharmacist-led medication reconciliation (PL-MR) | Total number of preventable ADEs (review of electronic health record and patient interview) |
| Batra | Prospective medical record review | Inpatient wards of 627-bed teaching hospital | 186 admissions for 105 patients with HIV | Pharmacist-led medication reconciliation (PL-MR) | Number of patients with prescribing errors (chart review) |
| Beckett | Prospective randomised, non-blinded study | Patients admitted to one of two general medicine floors or one general surgery floor | 41 (intervention), 40 (control) | Pharmacist-led medication reconciliation (PL-MR) | Medication discrepancies identified (chart review, patient and family interview) |
| Boockvar | Cluster-randomised controlled trial | An inpatient unit of an urban veteran affair hospital with responsible specialties of medicine, surgery or psychiatry | 186 (intervention), 195 (control) | Pharmacist-led medication reconciliation (PL-MR) | Medication discrepancies (prescription coverage plan review, patients, family members, providers interviews) |
| Cadman | Pilot randomised controlled trial | Five adult medical wards of a hospital | 96 (intervention), 102 (control) | Pharmacist-led medication reconciliation (PL-MR) | UDs (chart review, general practitioner and patient notes) |
| Tong | Unblinded, cluster randomised, controlled study | General medical unit of an adult major referral hospital | 431 (control), 401 (intervention) | Pharmacist-led medication reconciliation (PL-MR) | Patients’ discharge summaries with at least one medication error (prescribing errors) (discharge summary) |
|
| |||||
| Allison | Retrospective medical chart review of pre-post intervention | Medical settings of a tertiary hospital | 100 (pre-intervention), 100 (post-intervention) | Electronic discharge medication reconciliation tool (IT-MR) | Patients with at least one discharge antibiotic medication error (prescribing error) (chart review) |
| Smith | Pre–post quasi-experimental study | General medicine, geriatrics, cardiology inpatients | 317 (pre-intervention), 243 (post-intervention) | IT-MR | Discharge medication errors (prescribing errors) (electronic medical record and chart review) |
|
| |||||
| Schnipper | Quality improvement study | Medical or surgical units across 5 hospitals, no control units at hospital sites 4 and 5, no intervention units at hospital site 1 | 857 (control), 791 (intervention) | Local implementation of medication reconciliation best practices | Potentially harmful discrepancies in admission and discharge orders per patient (chart review) |
|
| |||||
| Hernandez | Before and after observational study | 66-bed orthopaedic surgery unit of a 700-bed teaching hospital | 111 (pre-CPOE), 86 patients (post-CPOE) | CPOE with alerts for drug-allergy checking, therapeutic duplications, dose-range and age-based checking, and drug–drug interactions. No mention of CDSS | Prescribing errors (direct disguised observation) |
| Milani | Prospective intervention | Patients with chronic kidney disease admitted with acute coronary syndrome to medical ward | 33 (intervention), 47 (control) | CPOE with alerts and CDSS for choice of medication, drug dosing based on clinical risk, patient weight, calculated creatinine clearance and consensus guidelines | Adverse drug events (Chart review) |
| Pettit | Retrospective single centre, pre-post intervention study | Patients admitted to a 811-bed academic medical centre who continued on antiretroviral therapy | 167 (pre-intervention), 131 (post-intervention) | CPOE with alerts to drug-interactions and information on medication guidelines. No mention of CDSS | Prescribing errors (chart review) |
| Shawahna | Prospective review study | Various wards of hospital, three medical wards in one teaching hospital | Not available | Paper based | Prescribing errors (chart review) (no numerator or denominator provided for medical wards) |
| van Doormaal | Interrupted time-series design | Two medical wards of a university hospital and two medical wards of a teaching hospital | 592 (baseline) | CPOE with alerts for drug interactions, overdoses and allergies, no CDSS | Prescribing errors (chart review) |
|
| |||||
| Garcia-Molina Saez | Quasi-experimental interrupted time-series study | Cardio-pneumology unit of general hospital | 3 phases: total 321 patients | PP | Reconciliation errors (structured interview with patients or family) |
| Hassan | Pre intervention and post intervention study | 35-bed nephrology unit | 300 (intervention), 300 (control) | PP | Suspected ADEs (chart review and ward round participation) |
| Liedtke | Retrospective observational study | HIV-seropositive patients admitted to a large teaching hospital | Total 330 patient admissions: | PP | Total number of prescribing errors (sum of the above numbers) (chart review) |
|
| |||||
| Gursanscky | Cluster randomised trial involving prescribers | Four general medical units of a tertiary hospital | Intervention on doctors: 12 interns, 4 registrars | PE | Prescribing errors (chart review) |
|
| |||||
| Weingart | Prospective randomised, controlled pilot trial | 40-bed general medicine unit of a Boston teaching hospital | 107 (intervention), 102 (control) | PTE | ADEs (chart review) |
|
| |||||
| Baqir | Quasi-experimental study | One acute surgical and one acute medical ward at a district general hospital | 181 (intervention), 230 (intra-ward control), 369 (inter-ward control) | TME | Patient with at least one unacceptable omitted dose (administration errors) (chart review) |
| Greengold | Randomised, direct observation study | Medical and surgical units of an academic community hospital and a university teaching hospital | Total number of nurses: | TME | Medication administration errors (observation) |
| Nguyen | Process improvement study | One medical-surgical ward in academic teaching hospital | Total number of nurses: 45 | TME - | Medication administration errors (observation) |
| Schneider | Randomised, controlled, non-blinded study | Medical or medical-surgical units of three university hospitals | Total number of nurses: 30, assigned to either control or intervention group. | TME – CD-ROM to nurses | Medication administration error rate (incorrect time, dose preparation and technique) (observation): |
|
| |||||
| Dean and Barber[ | Prospective observational, before and after study | Medical ward and surgical ward of teaching hospital | 23 patients (surgical ward) | Patients bringing in own medications | Administration errors (observation): |
| Schimmel | Prospective observational before and after study | 30-bed orthopaedic ward in a university medical centre | 45 (pre-intervention), 46 (post-intervention) | MD | Medication administration errors (observation) |
|
| |||||
| Cousein | Before–after observational study | 40-bed short stay geriatric unit within a 1800 bed general hospital | 148 (pre-intervention), 166 (post intervention) | DD | Administration error rates (observation) |
|
| |||||
| Cann | Pre–post test design | 29-bed acute surgical ward at tertiary-level regional hospital | 1115 (pre-intervention), 1069 (post-intervention) | PE, PP | Medication errors (did not specify which type) (online clinical incident reporting) |
| Daniels | Prospective intervention | HIV-infected patients admitted to a 803-bed academic medical centre | 78 (intervention), 68 (control) | PE, CPOE | Types of errors (inpatient pharmacy medication system) |
| Gimenez-Manzorro | Pre–post intervention study with no equivalent control group | General surgery department | 107 (pre-intervention), 84 (post-intervention) | CPOE, IT-MR | Unintended discrepancies (prescribing errors) (patient interview) |
| Grimes | Uncontrolled before–after study | Four acute medical care wards | 112 intervention group, 121 standard | PL-MR, PP | Errors on admission (prescribing errors) (pre-admission medication list, chart review, discharge medication list) |
| Jheeta | Interrupted time series, pre–post intervention study | A 14-bed elderly medicine inpatient ward in a large teaching hospital | 86 (pre-intervention), 86 (post-intervention) | CPOE + electronic admin system (CA) | Medication administration errors (observation) |
| Moura | Quasi-experimental study | A 172-bed public institution providing primary and tertiary care | 1852 (pre-intervention), 295 (intervention) | CPOE, PP | Incidence rate of all drug-drug interactions (chart review) |
| Shea | Retrospective comparative cohort study | HIV-infected patients admitted to a 244-bed urban academic medical centre | Total 234 patient admissions | PE, PL-MR | Patient admissions with prescribing errors (chart review) |
|
| |||||
| Sanders | Retrospective before–after study | HIV infected patients admitted to a large academic medical centre | 162 (pre-intervention), 110 (post-intervention) | CPOE, PE, IC | Prescribing errors (chart review) |
ADE, adverse drug event; CA, CPOE + electronic administration system; CDSS, CPOE with or without clinical decision support system; CPOE, computerised physician order entry; DD, automated drug distribution system; eMAR, electronic medication administration record; HIV, human immunodeficiency virus; IC, interdisciplinary collaboration; IT-MR, computerised medication reconciliation; MD, medication dispensing; PE, prescriber education; PL-MR, pharmacist-led medication reconciliation; PP, pharmacist partnership; PTE, patient education; TME, trained medication experts; UD, unintentional discrepancies; UK, United Kingdom; US, United States.
Figure 1.PRISMA flow diagram. Some studies examined more than one type of medication error.
PRISMA, preferred reporting items for systematic reviews and meta-analyses.
Quality assessment for randomized controlled trials and cluster randomized controlled trials using the CONSORT guidelines (n = 9).
| Reference (Country) (intervention) | Study design | Title and Abst | Intro | Trial Desig | Part | Int | Outc | Sp Sz | Rand Seq Gen | Rand Alloc | Rand Impl | Blind | Stat. Meth | Part Flow | Recru | Bas. Data | Num Ana | Out & Est | Anc Anal | Harm | Lim. | Gen | Intp | Reg | Prot | Fund | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Al-Hashar | Prospective randomised controlled study | 1/2 | 2/2 | 1/2 | 2/2 | 1/1 | 1/2 | 1/2 | 2/2 | 1/1 | 1/1 | 0/2 | 1/2 | 2/2 | 1/2 | 1/1 | 1/1 | 1/2 | 1/1 | 0/1 | 1/1 | 1/1 | 1/1 | 1/1 | 0/1 | 1/1 | 26/37 |
| Beckett | Prospective randomised, non-blinded study | 1/2 | 2/2 | 1/2 | 2/2 | 1/1 | 1/2 | 0/2 | 1/2 | 0/1 | 1/1 | 0/2 | 1/2 | 1/2 | 1/2 | 1/1 | 1/1 | 1/2 | 0/1 | 0/1 | 1/1 | 1/1 | 1/1 | 0/1 | 0/1 | 1/1 | 20/37 |
| Boockvar | Cluster-randomised controlled trial | 2/2 | 2/2 | 2/2 | 2/2 | 1/1 | 1/2 | 1/2 | 0/2 | 0/1 | 0/3 | 1/2 | 2/2 | 2/2 | 1/2 | 1/1 | 1/1 | 1/2 | 1/1 | 0/1 | 1/1 | 1/1 | 1/1 | 1/1 | 1/1 | 1/1 | 27/39 |
| Cadman | Pilot randomised controlled trial | 2/2 | 2/2 | 2/2 | 2/2 | 1/1 | 1/2 | 1/2 | 2/2 | 1/1 | 1/1 | 0/2 | 2/2 | 1/2 | 1/2 | 0/1 | 1/1 | 1/2 | 0/1 | 0/1 | 1/1 | 1/1 | 1/1 | 1/1 | 0/1 | 1/1 | 26/37 |
| Tong | Unblinded, cluster randomised, controlled study | 2/2 | 2/2 | 1/2 | 2/2 | 1/1 | 1/2 | 1/2 | 1/2 | 1/1 | 2/3 | 0/2 | 1/2 | 2/2 | 1/2 | 1/1 | 1/1 | 1/2 | 0/1 | 0/1 | 1/1 | 1/1 | 1/1 | 1/1 | 0/1 | 1/1 | 26/39 |
| Gursanscky | Cluster randomised trial involving prescribers | 1/2 | 2/2 | 2/2 | 2/2 | 1/1 | 0/2 | 0/2 | 1/2 | 1/1 | 1/3 | 1/2 | 2/2 | 1/2 | 1/2 | 0/1 | 1/1 | 1/2 | 1/1 | 0/1 | 1/1 | 1/1 | 1/1 | 0/1 | 0/1 | 0/1 | 22/39 |
| Weingart | Prospective randomised, controlled pilot trial | 1/2 | 2/2 | 1/2 | 2/2 | 1/1 | 0/2 | 0/2 | 1/2 | 1/1 | 1/1 | 1/2 | 2/2 | 2/2 | 1/2 | 1/1 | 1/1 | 1/2 | 1/1 | 0/1 | 1/1 | 1/1 | 1/1 | 0/1 | 1/1 | 1/1 | 25/37 |
| Greengold | Randomised, direct observation study | 2/2 | 2/2 | 1/2 | 1/2 | 1/1 | 1/2 | 0/2 | 1/2 | 1/1 | 1/1 | 0/2 | 1/2 | 0/2 | 1/2 | 0/1 | 1/1 | 1/2 | 0/1 | 0/1 | 1/1 | 1/1 | 1/1 | 0/1 | 0/1 | 0/1 | 18/37 |
| Schneider | Randomised, controlled, non-blinded study | 1/2 | 1/2 | 2/2 | 2/2 | 1/2 | 1/2 | 1/2 | 2/2 | 0/1 | 0/1 | 0/2 | 1/2 | 1/2 | 0/2 | 2/2 | 2/2 | 2/2 | 1/1 | 0/1 | 0/1 | 0/1 | 1/1 | 0/1 | 0/1 | 1/1 | 22/37 |
Anc Anal, ancillary analyses; Bas Data, baseline data; Blind, blinding; Fund, funding; Gen, generalizability; Harm, harms, Int, interventions; Intp, interpretation; Intro, introduction; Lim, limitations; Num Ana, numbers analysed; Out & Est, outcomes and estimation; Outc, outcomes; Part, participants; Part Flow, participant flow; PE, prescriber education; PL-MR, pharmacist-led medication reconciliation; Prot, protocol; PTE, patient education; Rand Alloc, randomisation allocation; Rand Impl, randomisation implementation; Rand Seq Gen, randomisation sequence generation; Recru, recruitment; Reg, registration; Sp Sz, sample size; Stat Meth, statistical methods; Title & Abst, title and abstract; TME; trained medication experts; Trial Desig, trial design; US, United States.
Quality assessment for the quality improvement study using the SQUIRE guidelines (n = 2).
| Reference (Country) (intervention) | Title | Abst | Prob. desc | Avail know | Ration | Spec aims | Context | Interv | Study of the interv | Measu | Analy | Eth consid | Results | Summary | Interp | Limit | Conclu | Fund | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schnipper | 1/1 | 2/2 | 1/1 | 1/1 | 1/1 | 1/1 | 1/1 | 1/2 | 2/2 | 1/3 | 2/2 | 0/1 | 5/6 | 2/2 | 5/5 | 3/3 | 2/5 | 1/1 | 32/40 |
| Nguyen | 1/1 | 1/1 | 1/1 | 1/1 | 0/1 | 0/1 | 0/1 | 1/2 | 1/2 | 1/3 | 0/2 | 1/1 | 3/6 | 1/2 | 2/5 | 2/3 | 2/5 | 1/1 | 19/40 |
Abst, abstract; Analy, analysis; Avail Know, available knowledge; Conclu, conclusions; Eth Consid, ethical consideration; Fund, funding; Interp, interpretation; Interv, intervention; Limit, limitations, Measu, measures; MR, medication reconciliation; Prob Desc, problem description; Ration, rationale; Spec Aims, specific aims; Study of the Interv, study of the intervention; TME, trained medication experts; US, United States.
Quality assessment for quasi-experimental studies using the TREND guidelines (n = 23).
| Reference (Country) (intervention) | Title and abst | Bgd | Partic | Int | Obj | Outc | Sp Sz | Assign. mtd | Bld | Unit of anal | Stat mtd | Part flow | Recru | Basel data | Basel equiv | No anal | Outc & estim | Anc anal | Adv ev | Inter | Gen | Ov evid | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Batra | 2/3 | 1/2 | 4/4 | 3/9 | 1/1 | 1/3 | 0/1 | 0/3 | 0/1 | 1/2 | 3/4 | 2/7 | 1/1 | 1/4 | 0/1 | 1/2 | 1/3 | 0/1 | 0/1 | 2/4 | 0/1 | 1/1 | 25/59 |
| Allison | 1/3 | 1/2 | 4/4 | 5/9 | 1/1 | 2/3 | 0/1 | 0/3 | 0/1 | 1/2 | 3/4 | 4/7 | 1/1 | 3/4 | 1/1 | 1/2 | 1/3 | 0/1 | 0/1 | 3/4 | 1/1 | 1/1 | 34/59 |
| Smith | 2/3 | 1/2 | 4/4 | 4/9 | 1/1 | 2/3 | 1/1 | 0/3 | 0/1 | 1/2 | 2/4 | 1/7 | 1/1 | 3/4 | 1/1 | 1/2 | 3/3 | 1/1 | 0/1 | 3/4 | 0/1 | 1/1 | 33/59 |
| Hernandez | 2/3 | 1/2 | 4/4 | 4/9 | 1/1 | 1/3 | 0/1 | 0/3 | 1/1 | 1/2 | 2/4 | 1/7 | 1/1 | 3/4 | 0/1 | 1/2 | 2/3 | 1/1 | 0/1 | 3/4 | 0/1 | 1/1 | 30/59 |
| Milani | 2/3 | 1/2 | 4/4 | 4/9 | 1/1 | 1/3 | 0/1 | 0/3 | 0/1 | 1/2 | 3/4 | 3/7 | 1/1 | 2/4 | 1/1 | 1/2 | 1/3 | 1/1 | 0/1 | 3/4 | 1/1 | 1/1 | 32/59 |
| Pettit | 2/3 | 1/2 | 4/4 | 4/9 | 1/1 | 1/3 | 0/1 | 0/3 | 0/1 | 1/2 | 2/4 | 1/7 | 1/1 | 0/4 | 0/1 | 1/2 | 1/3 | 1/1 | 0/1 | 3/4 | 0/1 | 1/1 | 25/59 |
| Shawahna | 3/3 | 1/2 | 2/4 | 5/9 | 1/1 | 2/3 | 0/1 | 1/3 | 1/1 | 0/2 | 2/4 | 0/7 | 0/1 | 0/4 | 0/1 | 1/2 | 2/3 | 1/1 | 1/1 | 2/4 | 0/1 | 1/1 | 26/59 |
| van Doormaal | 2/3 | 1/2 | 2/4 | 7/9 | 1/1 | 3/3 | 1/1 | 2/3 | 0/1 | 1/2 | 2/4 | 5/7 | 1/1 | 3/4 | 1/1 | 2/2 | 2/3 | 1/1 | 1/1 | 3/4 | 1/1 | 1/1 | 43/59 |
| Garcia-Molina Saez | 2/3 | 1/2 | 4/4 | 5/9 | 1/1 | 1/3 | 0/1 | 0/3 | 0/1 | 1/2 | 3/4 | 2/7 | 1/1 | 3/4 | 1/1 | 1/2 | 1/3 | 1/1 | 0/1 | 3/4 | 1/1 | 1/1 | 33/59 |
| Hassan | 2/3 | 1/2 | 4/4 | 4/9 | 1/1 | 1/3 | 0/1 | 0/3 | 0/1 | 1/2 | 3/4 | 0/7 | 1/1 | 1/4 | 1/1 | 1/2 | 1/3 | 0/1 | 0/1 | 3/4 | 1/1 | 1/1 | 27/59 |
| Liedtke | 3/3 | 1/2 | 4/4 | 4/9 | 1/1 | 2/3 | 0/1 | 0/3 | 1/1 | 1/2 | 3/4 | 2/7 | 1/1 | 3/4 | 0/1 | 1/2 | 1/3 | 0/1 | 0/1 | 3/4 | 1/1 | 1/1 | 33/59 |
| Dean and Barber[ | 1/3 | 1/2 | 2/4 | 4/9 | 1/1 | 3/3 | 1/1 | 2/3 | 0/1 | 2/2 | 3/4 | 2/7 | 0/1 | 0/4 | 0/1 | 1/2 | 3/3 | 1/1 | 1/1 | 4/4 | 1/1 | 1/1 | 34/59 |
| Schimmel | 2/3 | 1/2 | 3/4 | 4/9 | 1/1 | 2/3 | 1/1 | 0/3 | 0/1 | 1/2 | 3/4 | 2/7 | 1/1 | 2/4 | 1/1 | 1/2 | 2/3 | 0/1 | 0/1 | 3/4 | 0/1 | 1/1 | 31/59 |
| Baqir | 2/3 | 1/2 | 4/4 | 5/9 | 1/1 | 2/3 | 0/1 | 0/3 | 0/1 | 1/2 | 3/4 | 3/7 | 1/1 | 0/4 | 0/1 | 1/2 | 1/3 | 0/1 | 0/1 | 4/4 | 1/1 | 1/1 | 31/59 |
| Cann | 2/3 | 1/2 | 3/4 | 5/9 | 1/1 | 2/3 | 0/1 | 0/3 | 0/1 | 1/2 | 2/4 | 1/7 | 1/1 | 0/4 | 0/1 | 1/2 | 2/3 | 0/1 | 0/1 | 3/4 | 1/1 | 1/1 | 27/59 |
| Daniels | 2/3 | 1/2 | 4/4 | 5/9 | 1/1 | 2/3 | 0/1 | 0/3 | 0/1 | 1/2 | 0/4 | 0/7 | 1/1 | 0/4 | 0/1 | 1/2 | 1/3 | 0/1 | 0/1 | 3/4 | 1/1 | 1/1 | 24/59 |
| Gimenez-Manzorro | 2/3 | 1/2 | 4/4 | 4/9 | 1/1 | 2/3 | 1/1 | 1/3 | 0/1 | 1/2 | 3/4 | 5/7 | 1/1 | 3/4 | 1/1 | 1/2 | 1/3 | 0/1 | 0/1 | 4/4 | 1/1 | 1/1 | 38/59 |
| Grimes | 2/3 | 1/2 | 4/4 | 5/9 | 1/1 | 2/3 | 0/1 | 1/3 | 0/1 | 1/2 | 3/4 | 1/7 | 1/1 | 3/4 | 1/1 | 1/2 | 3/3 | 1/1 | 0/1 | 3/4 | 1/1 | 1/1 | 36/59 |
| Moura | 2/3 | 1/2 | 4/4 | 4/9 | 1/1 | 2/3 | 0/1 | 0/3 | 0/1 | 1/2 | 3/4 | 0/7 | 1/1 | 1/4 | 0/1 | 1/2 | 1/3 | 0/1 | 0/1 | 2/4 | 0/1 | 1/1 | 25/59 |
| Shea | 2/3 | 1/2 | 4/4 | 4/9 | 1/1 | 2/3 | 0/1 | 0/3 | 0/1 | 1/2 | 3/4 | 3/7 | 1/1 | 0/4 | 0/1 | 1/2 | 1/3 | 0/1 | 0/1 | 3/4 | 1/1 | 1/1 | 29/59 |
| Sanders | 2/3 | 1/2 | 4/4 | 5/9 | 1/1 | 1/3 | 0/1 | 0/3 | 0/1 | 1/2 | 3/4 | 1/7 | 1/1 | 3/4 | 1/1 | 1/2 | 3/3 | 1/1 | 0/1 | 3/4 | 0/1 | 0/1 | 32/59 |
| Cousein | 2/3 | 1/2 | 3/4 | 4/9 | 1/1 | 1/3 | 0/1 | 0/3 | 1/1 | 1/2 | 3/4 | 0/7 | 1/1 | 3/4 | 1/1 | 1/2 | 1/3 | 0/1 | 0/1 | 3/4 | 0/1 | 1/1 | 28/59 |
| Jheeta | 2/3 | 1/2 | 1/4 | 4/9 | 1/1 | 1/3 | 0/1 | 0/3 | 0/1 | 1/2 | 1/4 | 2/7 | 1/1 | 0/4 | 0/1 | 1/2 | 1/3 | 0/1 | 0/1 | 3/4 | 0/1 | 1/1 | 21/59 |
Adv Ev, adverse events; Anc Anal, ancillary analyses; Assign Mtd, assignment method; Basel Data, baseline data; Basel Equiv, baseline equivalence; Bgd, background; Bld, blinding; CA, electronic administration system, CDSS, clinical decision support system; CPOE, computerized physician order entry; DD, automated drug distribution system, Gen, generalizability; Int, interventions; Inter, interpretation; IT-MR, computerized medication reconciliation; MD, medication dispensing; No Anal, numbers analysed; Obj, objectives; Out, outcomes; Outc & Estim, outcomes and estimation; Ov Evid, overall evidence; Part Flow, participant flow; Partic, participants; PE, prescriber education; PL-MR, pharmacist-Led medication reconciliation; PP, pharmacist partnership; Recru, recruitment; Sp Sz, sample size; Stat Mtd, statistical methods; Title & Abst, title and abstract; TME, trained medication experts; Unit of Anal, unit of analysis; UK, United Kingdom; US, United States.
Figure 2.Risk of bias graph.
Figure 3.Risk of bias summary.
Types of interventions.
| PL-MR | Pharmacists identify the most accurate list of medications and provide patients with the correct medications in hospital. This is usually conducted at admission and/or discharge. |
| IT-MR | Electronic systems are used to identify the most accurate list of medications and provide patients with the correct medications in hospital. This is usually conducted at admission and/or discharge. |
| CPOE with or without CDSS | Electronic systems designed to automates the medication order process with the use of standardized and complete order. Sometimes this is complemented with the availability of CDSS, providing information on medication dose, route, and frequency. |
| PP | Pharmacists involved as part of the team. This can include ward rounds, providing monitoring service and/or prescription reviews. |
| PE | Educating the prescribers through online modules or pharmacist-led sessions. |
| PTE | Patient education especially on the medical terms on how to take the medication. This is usually conducted by pharmacists. |
| IC | Collaboration with various health care discipline groups for better medication management. |
| TME | Experts who were trained in medication administration. |
| CA | Electronic systems designed to facilitate medication administration. |
| DD | Electronic systems designed to facilitate medication administration |
| eMAR | Electronic records that comprise tools for medication prescription and administration. |
| MD | Different methods of medication cart filling methods to facilitate administration, for example, medications arranged by round time or by their names. |
CA, CPOE + electronic administration system; CDSS, CPOE with or without clinical decision support system; CPOE, computerised physician order entry; DD, automated drug distribution system; IC, interdisciplinary collaboration; IT-MR, computerised medication reconciliation; MD, medication dispensing; PE, prescriber education; PL-MR, pharmacist-led medication reconciliation; PP, pharmacist partnership; PTE, patient education; TME, trained medication experts.
Figure 4.Risk ratio summary for prescription errors.
Figure 5.Standard mean difference summary for prescribing errors.
Figure 6.Risk ratio summary for administration errors.
Figure 7.Risk ratio summary for dispensing errors.